Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy
US9726669B2 · kind B2 · utility
1Cited by
11References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2010 |
| Grant date | Aug 8, 2017 |
| Priority date | — |
| Expiry date | May 4, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.